The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Asthma News
Asthma News - October 1, 2026
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails at MDHHS-Asthma@michigan.gov.
Check out the most recent MDHHS asthma social media messages and share them with your networks.
MI Dept. of Health & Human Services: MI Asthma Dashboard - Detroit: The Asthma Burden, 2020-2024
Using survey, hospitalization, Medicaid claims, and mortality data, this dashboard displays the disparities of the asthma burden in the Detroit region compared with the rest of Michigan, from 2020 to 2024.Allergy & Asthma Network: Biosimilar Medication Omlyclo® is Now Available
The first biosimilar medication for respiratory, allergic and inflammatory conditions — Omlyclo® (omalizumab) — is now available in the US. Omlyclo is an interchangeable biosimilar for Xolair® (omalizumab). it is approved to treat moderate to severe persistent asthma in adult and pediatric patients ages 6 and older and other allergic conditions.
Truth Initiative: Nicotine prevention and quit resources: top tips for parents and educators
Find information for parents, educators, and others working with young people, including free resources like Vaping: Know the truth, a free digital curriculum that guides middle and high school students through real-world scenarios in a peer-to-peer voice.
Associations between genetic ancestry and allergic outcomes at 10 years among Black children
Among Black children, percent African ancestry is associated with an increased risk of asthma, allergen-specific IgE sensitization, and decreased lung function at 10 years.
Dysregulated tissue immunity in human fatal asthma
A new study revealed mucosal immune dysregulation underlying asthma exacerbation through site-specific and inter-tissue disruption of immune homeostasis in human organ donors who died of fatal asthma.
Associations between self-reported SARS-CoV-2 infections and the diagnosis of new health conditions
Repeated SARS-CoV-2 infections may increase the risk of reporting newly diagnosed health conditions (including asthma). Findings regarding acute infection severity and longer-term symptoms should be interpreted cautiously. Both of these factors may have increased care seeking and opportunities for diagnoses and may be the consequence of a new health condition.